Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

sequence

sequence is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 64
News articles 0
Drug details — sequence
Class
—
Route
—
Patents
20
Programs
64
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

sequence is an FDA-listed pharmaceutical active ingredient.

Key facts

INN sequence

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 241502 Phase 3 · Takeda · Hemophilia A
  2. 54767414MMY2093 Phase 2 · Janssen-Cilag International N.V · Multiple Myeloma
  3. METFORMIN , Placebo 515 Phase 2 · PARItec · Portal hypertension (PHT) and consequences in complications
  4. 01-AMO-CLA-BIO-25 Phase 1 · Zaklady FarmaFarmaceutyczne Polpharma · infections
  5. 01-DAP-BIO-24 Phase 1 · Zaklady FarmaFarmaceutyczne Polpharma · intended for treatment of for the treatment of (2): • insuf
  6. 01/2023/Pozlab Phase 1 · APREMEDA s.r.o · increased blood clotting
  7. 1019/25 Phase 1 · Tillomed Laboratories · Bioavailability study in healthy volunteers under fed condit
  8. 1062/25 Phase 1 · Tillomed Laboratories · Bioavailability study in healthy volunteers under fasting co

Related patents

Browse patents

  1. US 12410418

    Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12378560

    Sequence multiplicity within spherical nucleic acids

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12351839

    Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12319729

    Anti-Staphylococcus aureus specific antibody and nucleic acid encoding sequence thereof, and uses of the same

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12221483

    Fusion protein and nucleic acid encoding sequence thereof, and uses of the same

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12220446

    Use of upstream open reading frame 45aa-uORF nucleotide sequence of PTEN gene and polypeptide coded by 45aa-uORF

    Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12138301

    Compounds including a mutant KRAS sequence and a lipid and uses thereof

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12049479

    Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom

    Expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12012454

    Anti-tumor antigen nanobody and nucleic acid encoding sequence thereof, and uses of the same

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12006522

    Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11993793

    Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11898207

    Methods of isolating neoantigen-specific T cell receptor sequences

    Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11788077

    Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11753630

    Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11685784

    Anti-immune-checkpoint nanobody and nucleic acid encoding sequence thereof, and uses of the same

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11680254

    Engineered meganucleases specific for recognition sequences in the PCSK9 gene

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11661599

    CRISPR-Cas based system for targeting single-stranded sequences

    Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11642366

    Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy

    Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11613754

    Toxic RNAi active seed sequences for killing cancer cells

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11566255

    Expression of PEDV sequences in plants and plant produced vaccine for same

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is sequence?

sequence is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.